Literatur
- 1
Hauswirth A W, Simonitsch-Klupp I, Uffmann M, Koller E, Sperr W R, Lechner K, Valent P.
Response to therapy with interferon aplha-2b and prednisolone in aggressive mastocytosis:
report of five cases and review of the literature.
Leukemia research.
2004;
28
249-257
- 2
Kluin-Nelemanns H C, Oldhoff J M, van Doormaal J J, vanŽt Wout J W, Verhoef G, Gerrits W BJ,
van Dobbenburgh O A, Pasmans S G, Fijnheer R.
Cladribine therapy for systemic mastocytosis.
Blood.
2003;
102
4270-4276
- 3
Tefferi A, Pardanani A.
Clinical, genetic, and therapeutic insights into systemic mast cell disease.
Curr Opin Hematol.
2004;
11
58-64
- 4
Valent P, Sperr W, Schwartz L B, Horny H -P.
Diagnosis and classification of mast cell proliferative disorders: Delineation from
immunologic diseases and non-mast cell hematopoetic neoplasms.
J Allergy Clin Immunol.
2004;
114
3-11
Dr. med. Martin Sökler
Prof. Dr. med. Lothar Kanz
Medizinische Klinik, Abteilung für Hämatologie, Onkologie, Rheumatologie, Immunologie
und Pulmologie
Otfried-Müller-Straße 10
72076 Tübingen
